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INTRODUCTION 
 
Stroke is one of the leading causes of death and long term 
disability in India. Stroke is an important cause of premature death and 
disability in low-income and middle-income countries like India,  
largely driven by demographic changes and enhanced by the increasing 
prevalence of the key modifiable risk factors.  
Among all the neurological diseases of adult life, cerebrovacular 
accidents clearly ranks first in frequency of importance. Almost fifty 
percent of neurological diseases in general hospital are due to stroke.  
Cerebro vascular accident includes ischemic stroke, hemorrhagic 
stroke, and cerebro vascular anomalies such as intracranial aneurysm, AV 
malformation and cortical venous thrombosis. Stroke after heart disease, 
is the second most common cause of death among non-communicable 
diseases [1]. 
With the introduction of effective treatment for hypertension, there 
has been a marked reduction in the frequency of stroke.  
Diabetes mellitus by virtue of its association with micro vascular 
and macrovascular disease is an important risk factor in the genesis of 
stroke.[2]  
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Most of the diabetic patients with stroke have raised glycosylated 
hemoglobin indicating that most of them have uncontrolled diabetes. 
Diabetics and stress hyperglycemics have severe strokes resulting in poor 
outcome. Stroke is Twice more common in diabetics than in non 
diabetics. [3]  
Hypertension is common in diabetes and accelerates 
atherosclerosis which promotes intracranial small vessel disease and heart 
disease leading to lacunar and embolic infarction respectively. There are 
several risk factors that determine the outcome of stroke.  
Hyperglycemia, fever, neuroprotective agents are those which are 
widely studied.  
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AIMS AND OBJECTIVES 
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AIM OF THE STUDY 
 
To measure the random blood glucose level in the early phase of 
ischemic stroke (within 24 hours of onset) in both diabetics and in non 
diabetics and to evaluate the severity and prognosis in both diabetics and 
non diabetics in relation to hyperglycemia.  
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REVIEW OF LITERATURE  
 
DEFINITION :  
Stroke or cerebrovascular accident is a rapidly developing episode 
of focal and at times global deficit of cerebral function with symptoms 
lasting more than 24hours or leading to death with no apparent cause 
other than that of vascular origin.[4] 
Acute ischemic stroke is caused by thrombotic or embolic 
occlusion of a cerebral artery. 
Transient ischemic attack (TIA) is an acute loss of focal cerebral 
or monocular function with symptoms lasting less than 24hours.  
Reversible ischemic neurological deficit (RIND) refers to 
neurological deficit that disappears within 7 days of onset.  
EPIDEMIOLOGY  
Cerebrovascular disease or stroke is the fifth commonest among 
premature deaths in adults and fourth leading cause of death of all cause 
mortality in India. With both death and disability combined i.e., 
disability-adjusted life years (DALYs) stroke occupies the fifth position 
among all causes. 
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According to the World Health Organization (WHO), 15 million 
people suffer stroke worldwide each year. Of these, 5 million die, and 
another 5 million are left permanently disabled.  
RISK FACTORS 5  
NON-MODIFIABLE RISK FACTORS  
Age :  
Increasing age is most powerful risk factor for cerebral infarction, 
intracerebral hemorrhage and subarachnoid hemorrhage as well as TIA  
 
Sex :  
men are more at risk for ischemic stroke than woman up to  
75 years of age.  
 
Race :  
The risk is more in Blacks than Whites  
Hereditary :  
There is an increased incidence of stroke in individuals who have a 
first degree relative affected with stroke or who have paternal or maternal 
history of death or disability due to stroke and family history of TIA. 
 
History of migraine headaches :  
Is associated with all types of stroke more common among women. 
Fibromuscular dysplasia:  
Is more common among female patients. 
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MODIFIABLE RISK FACTORS  
Hypertension :  
Hypertension is a major risk factor for stroke. Hypertension is 
associated with an increased incidence of both haemorrhagic, ischaemic 
and lacunar stroke. It is an important predisposing factor not only for 
cerebral hemorrhage but also for infarction. Both systolic and diastolic 
pressures contribute to the risk though there is no critical level above 
which it operates. The reduction of BP by 10-12mmHg systolic and 5-
6mmHg diastolic was found to be associated with 38% reduction in 
stroke incidence.  
 
Diabetes mellitus :  
It is an independent risk factor for stroke. It increases the 
susceptibility to coronary, femoral, and cerebral atherosclerosis. The 
relative risk increases two to fourfold in diabetics patients with diabetic 
complications like retinopathy and autonomic neuropathy have a higher 
incidence of ischemic stroke  
 
Hyperglycemia And Stroke :  
Diabetes mellitus is an independent risk factor for stroke and one of 
the important risk factors causing strokes at younger ages. The 
mechanism is believed to be accelerated atherosclerosis, which can Affect 
vessels in many distributions, including small and large vessels. 
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Cardiac involvement may predispose to embolic strokes as well. In 
addition, patients with diabetes may have any of several lipid 
abnormalities. 
Elevated levels of triglycerides, low-density lipoproteins (LDL), 
and very low-density lipoproteins (VLDL), along with lower than normal 
levels of high-density lipoprotein (HDL), are common findings in the 
lipid profiles of patients with diabetes.  
The combined effect of these factors results in promotion of 
atherosclerosis and thrombosis. Elevated blood glucose is common in the 
early phase of stroke. The prevalence of hyperglycemia, defined as blood 
glucose level more than 126 mg/dl has been observed in two third of all 
ischemic stroke subtypes on admission. [6] 
Extensive experimental evidence in stroke models support that 
association between blood glucose and functional outcome has been 
found in increasing number of clinical studies.  
 
Causes of Acute Hyperglycemia :  
Although up to one third of acute stroke patients have either 
diagnosed or newly diabetic, probably a major proportion of patients have 
stress hyperglycemia, mediated partly by the release of cortisol and nor 
epinephrine. It is also a manifestation of relative insulin deficiency, which 
is associated with increased lipolysis even in non diabetic patients; stress 
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hyperglycemia may be a marker of glucose regulation in individuals with 
insulin resistance and developing diabetes.[7] 
 
Hypercholesterolemia :  
It is a secondary risk factor indirectly affecting the risk of stroke. 
Reducing high cholesterol levels decreases the incidence of coronary 
artery disease which is the main cause of mortality in patients with 
cerebro vascular disease.  
 
Non valvular atrial fibrillation :  
It is common in the age group of 65 - 85years and attributes to a 
five fold increase in the incidence of embolic stroke especially in those 
patients who have recent heart failure or thrombo embolism.  
 
Cigarette smoking :  
It increases the risk of infarction in men and women by 
predisposing to carotid atherosclerosis. Smokers experience a reduction 
in stroke risk only after 5 years following cessation of smoking.  
 
Alcohol :  
Light to moderate intake reduces the risk by increasing the HDL 
concentration, whereas heavy drinking increases the risk. More than one 
drink per day for women and more than two per day for men increases the 
BP, obesity and triglycerides level thereby increasing the risk.  
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TIA :  
Three times greater risk for subsequent stroke or death due to 
vascular causes, especially those with hemispherical TIA. Patients with a 
previous history of stroke are at risk for a subsequent stroke. The risk of 
stroke recurrence is increased by the presence of dementia.  
 
Carotid artery stenosis :  
Asymptomatic Carotid artery stenosis less than 75% carries a risk 
of 1.3% annually whereas risk increases to 10.5% per year if the stenosis 
is greater than 75%. Ulcerated .echoluscent and heterogeneous plaques 
with a soft-core are at higher risk for embolism.  
 
Blood factors :  
Elevated haematocrit, hemoglobin and viscosity of the blood is 
associated with increased risk of ischemic stroke. Higher mean levels of 
plasma fibrinogen, factor VIII, von willebrand’s factor, anti-thrombin III 
and lower mean levels of protein C is associated with increased risk. The 
Antiphospholipid antibodies is associated with increased risk of ischemic 
stroke. Serum folate concentration less than or equal to 9.2 nmol/L alone 
may be risk factor for ischemic stroke.  
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Hormones :  
High dose estrogen oral contraceptives increases the risk of stroke 
in young women, while postmenopausal estrogen supplementation 
reduces the risk. The risk of cerebral infarction is increased in the first 6 
weeks following delivery.  
 
Others :  
Abdominal or truncal obesity, physical inactivity, habitual snoring 
are associated with increased risk of ischemic stroke.  
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PATHOPHYSIOLOGY  
 
Stroke is 80% to 90% ischemic and 10 % hemorrhagic.[8] Abrupt 
disruption of focal cerebral blood flow causes acute ischemic stroke. 
Acute ischemic strokes result from vascular occlusion secondary to 
thromboembolic disease. Ischemia causes cell hypoxia and depletion of 
cellular adenosine triphosphate (ATP). Without ATP, there is no longer 
the energy to maintain ionic gradients across the cell membrane and cell 
depolarization. Influx of sodium and calcium ions and passive inflow of 
water into the cell lead to cytotoxic edema. The causes of decreased 
cerebral blood flow includes abrupt occlusion of small penetrating 
arteries arterioles, single or multiple arterial stenosis, arteritis, arterial 
dissection, venous occlusion, and profound anemia.  
An acute vascular occlusion produces heterogeneous regions of 
ischemia in the affected vascular territory. Local blood flow is limited to 
any residual flow in the major arterial source plus the collateral supply. 
Affected regions with cerebral blood flow of lower than 10 mL/100 
g of tissue/min are referred to collectively as the core. When cerebral 
blood flow falls below this then aerobic mitochondrial metabolism fails 
and anaerobic metabolism leads to lactic acidosis. These cells are 
presumed to die within minutes of stroke onset. 
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Zones of decreased or marginal perfusion (cerebral blood flow < 
25 mL/100g of tissue/min) are collectively called the ischemic penumbra. 
Tissue in the penumbra can remain viable for several hours because of 
marginal tissue perfusion. When cerebral blood flow falls below a critical 
value of 20ml /100g/min there is a loss of neuronal electrical function 
which is a reversible.  
As a sequel to this sodium and water enters the cell and potassium 
leaks out of the cell due to failure of energy dependent intracellular 
homoeostasis leading to irreversible cell death.  
Based on these facts the concept of ischemic penumbra was 
formulated. It is an area of brain that has reached the reversible stage of 
electrical failure but has not yet passed into the irreversible stage. 
Thrombolytic agents are used in this time window to salvage the 
ischemic penumbra zone.  
HOW ELEVATED GLUCOSE INJURES THE ISCHEMIC BRAIN  
By provoking anaerobic metabolism, lactic acidosis and free 
radical production, hyperglycemia may exert direct membrane lipid per 
oxidation and cell lysis in metabolically challenged tissues. Moderately 
and severely increased blood glucose has been found to further lower the 
mitochondrial function in the area and ischemic penumbra.[9] Insulin 
resistance is a known risk factor for the onset of stroke acting through a 
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number of intermediate vascular disease risk factors ( i.e. thrombophilia, 
endothelial dysfunction and inflammation ) [10].  
The evolution of acute infarction may be explained by the very 
same vascular factors, explaining why ischemic time seems to fly faster 
in patients with diabetes or grave hyperglycemia. Relative insulin 
deficiency liberates circulating free fatty acids, which together with 
hyperglycemia, diminishes vascular reactivity [11,12].  
Furthermore, lowering glucose with insulin has been reported to 
reduce ischemic brain damage. [13] 
The evolution of an infarction is accompanied by glutamate release 
mediating repeated waves of spreading depression (SD), another 
mechanism believed to propagate the necrosis of penumbral tissues. 
Although hyperglycemia alone did not trigger early response genes in 
cortical tissues of rats, in conjunction with induced SD, the expression of 
c-fos and cox-2 were substantially increased. [14]  
This suggested that increased glucose may trigger untoward 
intracellular biochemical cascades also by altering early gene expression 
in metabolically challenged neurons.  
The blood brain barrier is well known to be vulnerable to 
hyperglycemia, presumably through the liberation of lactic acid and free 
radicals.  
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The recent experimental study by Song et al in a rat model of 
collagenase induced intra cerebral hemorrhage add that hyperglycemia 
aggravates edema formation in zone surrounding the hemorrhage.[15] 
The study also documented increased cell death measured by TUNNEL 
staining. It is conceivable that hemorrhages are surrounded by a one of 
similarly challenged tissues as infarctions are where the availability of 
glucose influences the metabolic state.  
 
COMMON CAUSES OF ISCHEMIC STROKE :  
1.Thrombosis  
Lacunar stroke (small vessel)  
Large vessel thrombosis  
Dehydration  
2.Embolic occlusion  
A. Artery-to-artery  
Carotid bifurcation  
Aortic arch, Arterial dissection  
B. Cardio embolic  
Atrial fibrillation  
Mural thrombus  
Myocardial infarction  
Dilated cardiomyopathy  
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Valvular lesions  
Mitral stenosis  
Mechanical valve  
Bacterial endocarditis  
Paradoxical embolus  
Atrial septal defect  
Patent foramen ovale  
Atrial septal aneurysm  
Spontaneous echo contrast  
UNCOMMON CAUSES :  
1.  Hypercoagulable disorders  
Protein C deficiency  
Protein S deficiency  
Anti thrombin III deficiency  
Antiphospholipid syndrome  
Factor V Leiden mutation  
Prothrombin G20210 mutation  
Systemic malignancy  
Sickle cell anemia  
Beta Thalassemia  
Polycythemia Vera  
Systemic lupus erythematosus  
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Homocysteinemia  
Thrombotic thrombocytopenic purpura  
Disseminated intravascular coagulation  
Dysproteinemias  
Nephrotic syndrome  
Inflammatory bowel disease  
Oral contraceptives  
2. Venous sinus thrombosis  
3. Fibro muscular dysplasia  
4. Vasculitis  
5. Systemic vasculitis  
(PAN, Wegner's, Takayasu's, giant cell arteritis )  
Primary CNS vasculitis  
Meningitis (syphilis, tuberculosis, fungal, bacterial, zoster)  
6.  Cardiogenic  
Mitral valve calcification  
Atrial myxoma  
Intra cardiac tumor  
Marantic endocarditis  
Libman-Sacks endocarditis  
7. Subarachnoid hemorrhage vasospasm  
8. Drugs: cocaine, amphetamine  
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9. Moyamoya disease  
10. Eclampsia.  
 
CLINICAL SYNDROMES [5] 
TRANSIENT ISCHAEMIC ATTACKS  
TIAs are abrupt in onset , brief in duration and recovery is possible 
in 24 hours. Recurrent TIAs can occur. Recognition and treatment is 
important as a complete stroke can be prevented.  
 
Carotid TIAs  
These are characterized by monocular blindness with recovery 
within Few minutes, visual field disturbance in the form of transient 
hemianopia and speech disturbance due to dominant hemispherical 
dysfunction. Hemi paresis and hemi sensory loss can occur both in 
vertebro basilar TIAs as well as carotid TIAs.  
Vertebro Basilar TIAs  
These are characterized by prominent visual symptoms like 
Diplopia, homonymous hemianopia and cortical blindness, transient 
vertigo dizziness, unsteadiness due to cerebellar dysfunction and transient 
lower cranial nerve symptoms like dysarthria, perioral numbness, nasal 
regurgitation.  
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Drop attacks occur without any warning .It is thought to be due to 
ischemia of relays in reticular systems which normally function as part of 
reflex antigravity mechanism.  
 
Subclavian steal syndrome 
This syndrome occurs when there is occlusion of the Subclavian 
artery proximal to origin of vertebral artery which results in retrograde 
flow of blood down the vertebral artery during exercising the arm thereby 
leading on to symptoms of hindbrain ischemia.  
 
Mini Strokes  
Mini strokes are characterized by episodic ischemic symptoms 
which recover within 24 hours but there are small infarcts or hemorrhage 
in CT and are as significant as the TIAs.  
Stroke in evolution  
Stroke in evolution refers to the slow progression of neurological  
deficit over several hours.  
 
Major strokes  
Major stroke are of sudden onset with loss of consciousness at the 
onset or soon after. It is very difficult to distinguish clinically between 
infarction or hemorrhage. Headache and vomiting if present, usually 
denotes hemorrhage especially if it is associated with rapid loss of 
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consciousness. Athero –thrombo embolism is suggested by the presence 
of bruit over the carotid arteries.  
 
Unusual types of stroke  
Multi-infarct dementia, watershed infarction.  
Classification of stroke on the basis of oxford shire community stroke  
Sub classification [16] 
Total anterior circulation syndrome (TACS)  
Implies a large cortical stroke in middle cerebral or middle and  
anterior cerebral artery territories. it is characterized by a combination of 
new higher cerebral dysfunction Homonymous visual field defect an 
ipsilateral motor and / or sensory deficit involving at least two out of 
three areas of the face, arm or leg  
 
Partial anterior circulation syndrome  
Implies a cortical stroke in middle or anterior cerebral arterial 
territory. This includes patients with two out of three components of the 
Total anterior circulation syndromes or new higher cerebral dysfunction 
alone or motor / sensory deficit more restricted than those classified as a 
TACS.  
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Lacunar syndrome  
Implies a sub cortical stroke due to a small vessel disease  
 Pure motor stroke  
 Pure sensory stroke  
 sensory motor stroke  
 ataxic hemi paresis  
Evidence of higher cortical dysfunction or disturbance of 
consciousness excludes Lacunar syndrome.  
 
posterior circulation syndrome  
1. Ipsilateral cranial nerve palsy with contra lateral motor and sensory 
deficit,  
2. Bilateral motor and or sensory deficit  
3. Disorder of conjugate eye movement  
4. Cerebellar dysfunction without ipsilateral long tract involvement  
5. Isolated homonymous visual field defects  
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ANTERIOR CEREBRAL CIRCULATION SYNDROME 
No Signs and symptoms Structures involved 
1. Paralysis of opposite foot and leg Motor leg area 
2. 
Lesser degree of paresis of 
opposite arm 
Involvement of cortical / corona 
radiata of arm fibers 
3. 
Cortical sensory loss over toes, 
foot and leg 
Sensory area for foot and leg 
4. Urinary incontinence 
Sensory motor area in  
Para central lobule 
5. 
Contralateral grasp reflex, 
suckling reflex, gegenhalten 
Medial surface of the posterior 
frontal lobe 
6. 
Abulia, slowness, delay, 
intermittent interruption, lack of 
spontaneous whispering, reflex 
distraction to sights and sounds 
Cingulate gyrus, medial inferior 
portion of frontal, parietal and 
temporal lobes 
7. 
Impairment of gait and stance 
(gait apraxia) 
Frontal cortex near leg motor area 
8. 
Dyspraxia of left limbs, Tactile 
aphasia in left limbs 
Corpus callosum 
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MIDDLE CEREBRAL CIRCULATION SYNDROME 
No Signs and symptoms Structures involved 
1 
Paralysis of the contra lateral face, 
arm, and leg; sensory impairment 
over the same area (pinprick, cotton 
touch, vibration, position, two-point 
discrimination, stereognosis,  
tactile localization) 
Somatic motor area for face 
and arm and the fibers 
descending from the leg area to 
enter the corona radiata and 
corresponding somatic  
sensory system 
2 Motor aphasia 
Motor speech area of the 
dominant hemisphere 
3 
Central aphasia, word deafness, 
anomia, jargon speech, sensory 
agraphia, acalculia, alexia, finger 
agnosia, right-left confusion (the last 
four comprise the Gerstmann 
syndrome 
Central, suprasylvian speech 
area and parieto occipital 
cortex of the dominant 
hemisphere 
4 Conduction aphasia 
Central speech area (parietal 
operculum) 
5 
Apractognosia of the minor 
hemisphere (amorphosynthesis), 
anosognosia, hemiasomatognosia, 
unilateral neglect, agnosia for the 
left half of external space, dressing 
"apraxia," constructional "apraxia," 
distortion of visual coordinates, 
inaccurate localization in the half 
field, impaired ability to judge 
distance, upside-down reading, 
visual illusions (e.g., it may appear 
that another person walks through a 
table) 
Non dominant parietal lobe 
(area corresponding to speech 
area in dominant hemisphere); 
loss of topographic memory is 
usually due to a non dominant 
lesion, occasionally to a 
dominant one) 
6 
Homonymous hemianopia (often 
homonymous inferior 
quadrantanopia) 
Optic radiation deep to second 
temporal convolution 
7 
Paralysis of conjugate gaze to the 
opposite side 
Frontal contraversive field or 
projecting fibers 
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POSTERIOR CEREBRAL CIRCULATION SYNDROME 
Peripheral territory 
No Signs and symptoms Structures involved 
1 Homonymous hemianopia (often  
upper quadrantanopia) 
Calcarine cortex or optic 
radiation 
2 Bilateral homonymous hemianopia, 
cortical blindness, awareness or denial 
of blindness; tactile naming, 
achromatopia (color blindness), failure 
to see to-and-fro movements, inability 
to perceive objects not centrally 
located, apraxia of ocular movements, 
inability to count or enumerate objects, 
tendency to run into things that the 
patient sees and tries to avoid 
Bilateral occipital lobe with 
possibly the parietal lobe 
involved 
4 Verbal dyslexia without agraphia, color 
anomia 
Dominant calcarine lesion and 
posterior part of corpus 
callosum. 
5 Memory defect Hippocampal lesion bilaterally 
or on the 
dominant side only 
6 Topographic disorientation and 
prosopagnosia 
Non dominant, calcarine,  
and lingual gyrus. 
7 Simultagnosia, hemi visual neglect Dominant visual cortex,  
contra lateral hemisphere 
8 Unformed visual hallucinations, 
peduncular hallucinosis, 
metamorphosis, teleopsia, illusory 
visual spread, palinopsia, distortion of 
outlines, central photophobia 
Calcarine cortex. 
9 Complex hallucinations Non dominant hemisphere. 
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POSTERIOR CEREBRAL CIRCULATION SYNDROME 
Central territory 
No Signs and symptoms Structures involved 
1 
Thalamic syndrome: sensory loss (all 
modalities), spontaneous pain and 
dysesthesias, choreoathetosis, intention 
tremor, spasms of hand, mild hemi 
paresis 
Postero ventral nucleus of 
thalamus; involvement of 
the adjacent sub thalamus 
body or its afferent tracts 
2 
Thalamo perforate syndrome: crossed 
cerebellar ataxia with ipsilateral third 
nerve palsy (Claude's syndrome) 
Dentatothalamic tract and 
issuing third nerve 
3 
Weber's syndrome: third nerve palsy and 
contra lateral hemiplegia 
Third nerve and cerebral 
peduncle 
4 Contra lateral hemiplegia Cerebral peduncle 
5 
Paralysis or paresis of vertical eye 
movement, skew deviation, sluggish 
pupillary responses to light, slight miosis 
and ptosis (retraction nystagmus and 
"tucking" of the eyelids may be 
associated) 
Supranuclear fibers to third 
nerve, interstitial nucleus 
of Cajal, nucleus of 
Darkschewitsch, and 
posterior commissure 
6 
Contra lateral rhythmic, ataxic action 
tremor; rhythmic postural or "holding" 
tremor (rubral tremor) 
Dentatothalamic tract 
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DIAGNOSTIC EVALUATION OF ISCHAEMIC STROKE [17]  
The diagnostic evaluation should include parallel assessment of the 
following.  
1. Imaging of the infarct  
2. Vascular studies  
3. Cardiac evaluation  
4. Hematological and other blood testing  
 
Imaging  
CT scan brain is done to differentiate hemorrhage from infarction. 
Investigations must be ordered based on the possible etiology. Cerebral 
arteriography is needed if intra arterial thrombolysis is contemplated. 
Angiogram is done if vascular stenosis is suspected and if it is negative or 
if posterior circulation is suspected then, Tran cranial Doppler is done.  
 
CT versus MRI  
1. Only a minority infarction demonstrated within 24 hours on CT. 
MRI documents infarct as early 6 hours  
2. Anatomic extent and vascular distribution are better delineated in 
MRI. Small infarctions are easily seen and white matter better 
visualized.  
3. Posterior fossa infarctions are better visualized in MRI.  
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CT scan changes in cerebral infarction [18] 
Hyper acute infarct < 12 hours  
normal (50 – 60%)  
Hyper dense artery (25 – 50%)  
o Obscuration of Lentiform nuclei  
Acute infarct 12 to 24hours  
o Low density basal ganglia  
o Loss of grey white interfaces  
o Sulcal effacement  
1 to 3days  
o Increasing mass effect  
o Wedge shaped low density area that involves both 
grey&white matter 
o Hemorrhagic transformation may occur (basal ganglia and 
cortex are common sites)  
4 to 7days  
o Gyral enhancement  
o mass effect, edema persist  
 
1 to 8 weeks  
o Contrast enhancement persists  
o mass effect resolves  
 
  
30 
 
months to years  
o encephalomalacic changes  
o volume loss  
o calcification is rare  
 
Clinical Correlation of Hyperglycemia and Infarct Progression  
Although experimental studies have clarified several mechanisms 
by which hyperglycemia influences the destiny of ischemic brain issue, 
studies bridging the gap between clinical stroke and experimental models 
have been scare.  
Recent advances in Magnetic Resonance Imaging techniques have 
permitted Correlation of loss of penumbral tissue with elevated blood 
glucose, which was linked to increased brain lactate production. [19] 
Using a subcutaneous glucose sensor for continuous monitoring up to 
seventy two hours, the sane group could reproduce the findings that the 
infarcts expanded more in hyperglycemic patients and that hyperglycemia 
was independently associated with the infarct volume change. [20] This 
suggests that increased glucose not only reflects the initial volume of 
infracted tissue in the acute stage but is one of the true determinants of 
early infarct progression in men.  
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Neurological Pearls In Prognosis 
Factors predicting poor outcome [21] 
1. age : more than 75 years  
2. males : due to lack estrogen protective effect  
3. risk factors : atrial fibrillation, DM, previous stroke  
4. clinical findings  
o decreased consciousness at the onset  
o Presence of gaze deviation  
o Headache, nausea, vomiting in first 24 hours  
o Elevated systolic BP >180 mm Hg on first day  
o Hyperthermia on admission  
o NIHSS score of 16 or more  
o Large vessel disease  
5. Laboratory findings  
o High glutamine in plasma > 200 micromol / L  
o CRP concentration > 10.2 mg / l within 72 hours  
o Hyperglycemia > 126mg / dl  
o Platelet count < 150000 due to increased bleeding  
6. Neuro imaging studies  
o Hyper density in a major intra cranial artery  
o Early CT changes within 6 hours of onset  
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o >33 % of MCA territory involvement / multiple territory 
involvement with mass effect  
o Hemorrhagic transformation on follow up CT / on intra 
cranial Doppler persisting MCA occlusion for hours  
o No flow on SPECT perfusion patterns  
o Carotid artery occlusion on conventional angiogram  
o MCA , basilar artery occlusion on angiogram  
o MRI – abnormal PWI in diffusion and perfusion weighted 
imaging  
o MRA – absence of MCA is associated with poor prognosis  
 
PROGNOSIS AND HYPERGLYCEMIA  
Already ample literature has demonstrated that hyperglycemia on 
admission is associated with worsened clinical outcome as reviewed in a 
systemic overview of thirty three studies .[22] Glycemic control may be 
indicated also in non-diabetic patients, in which stress hyperglycemia was 
associated with a three fold risk of fatal thirty day outcome and 1.4 fold 
risk in of poor functional outcome.[23] 
Preexisting hyperglycemia worsens the clinical outcome of acute 
stroke. Nondiabetic ischemic stroke patients with hyperglycemia have a 
3-fold higher 30-day mortality rate than do patients without 
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hyperglycemia.[24] In diabetic patients with ischemic stroke, the 30-day 
mortality rate is 2-fold higher.[25] 
TREATMENT  
The first goal is to prevent or reverse brain injury. The second goal 
is to obtain an accurate understanding of the stroke mechanism so one can 
halt progression of brain injury or begin to prevent a second stroke  
Treatments designed to reverse or lessen the amount of tissue 
infarction fall Within five categories:  
1. Medical support  
2. Thrombolysis  
3. Anticoagulation  
4. Antiplatelet agents  
5. Neuroprotection  
 
(1)Medical Support  
1.When cerebral infarction occurs, the immediate goal is to 
optimize cerebral perfusion in the surrounding ischemic area  
2. Preventing the common complications of bedridden patients like 
infections (pneumonia, urinary tract, and skin), deep venous thrombosis 
with pulmonary embolism.  
3.Elevated BP should not be lowered unless there is malignant 
hypertension or concomitant myocardial ischemia. If the blood pressure 
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is low, raising it is advisable, using intravenous fluids or vasopressor 
drugs to enhance perfusion within the ischemic penumbra.  
4. Treatment of cerebral edema if necessary  
(2)Thrombolysis  
The use of thrombolytic agents in acute cerebral infarction has 
been studied extensively. Angiography performed within a few hours of 
infarction frequently demonstrates arterial occlusions corresponding to 
patients presenting signs and symptoms. It is this association of arterial 
occlusion with acute neurological symptoms that prompted the study of 
thrombolytic agents in stroke patients.  
Agent used for this purpose is intravenous recombinant tissue 
plasminogen activator (rtPA)  
 
Indication [26] 
Clinical diagnosis of ischemic stroke with clear symptom onset 
within 3 hours CT scan showing no hemorrhage or significant edema Age 
more than 18 years, Consent by patient or surrogate  
 
Contraindication [26] 
Sustained BP > 185/110  
Platelets < 100,000; HCT< 25%; glucose < 50 or > 400  
Use of heparin within 48 h and prolonged PTT, or elevated INR 
Rapidly improving symptoms Prior stroke or head injury within 3 
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months; prior intracranial hemorrhage Major surgery in preceding  
14 days Minor stroke symptoms Gastrointestinal bleeding in preceding 21 
days Recent myocardial infarction, Coma or stupor  
Administration of rtPA [27] 
Intravenous access with two peripheral IV lines (avoid arterial or 
central placement) Review eligibility for rtPA.  
Administer 0.9 mg/kg intravenously (maximum 90 mg) IV as 10% 
of total dose by bolus, followed by remainder of total dose over 1 h. 
Continuous blood pressure monitoring.  
No other antithrombotic treatment for 24 h.  
For decline in neurological status or uncontrolled blood pressure, 
stop infusion, give cryoprecipitate, and reimage brain emergently  
Avoid urethral catheterization for > 2 h.  
 
(3)Anticoagulation  
The role of anticoagulation in atherothrombotic cerebral ischemia 
is uncertain. Heparinization is generally accomplished by beginning an 
infusion without bolus and is monitored to maintain the activated PTT at 
approximately twice normal.  
This regimen is maintained for 2 to 5 days. During this time the 
patient is monitored for hemorrhagic complications, the evaluation is 
36 
 
completed decision is made regarding the need for carotid 
endarterectomy, long-term anticoagulation, or an antiplatelet therapy.  
If long-term anticoagulation is chosen, warfarin is administered 
and heparin discontinued when the international normalized ratio (INR) is 
in the range of 2 to 3.  
 
(4)Antiplatelet Agents  
Aspirin is the only antiplatelet agent that has been prospectively 
studied for the treatment of acute ischemic stroke. The use of aspirin 
within 48 h of stroke onset reduced both stroke recurrence risk and 
mortality minimally  
 
(5)Neuroprotection  
Neuroprotection is the concept of providing a treatment that 
prolongs the brain's tolerance to ischemia long enough to allow other 
measures to be employed to mitigate ischemia. Hyperthermia, 
Hyperglycemia are the agents which increases the size of the infarct, 
hence hypothermia and normalizing blood sugar are powerful 
neuroprotective agents.  
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HYPERGLYCEMIA AND THROMBOLYTIC THERAPHY OF 
ACUTE ISCHEMIC STROKE [28] 
In several thrombolysis trials, hyperglycemia has been associated 
With hemorrhagic events [29] as well as in a re- Analysis of the NINDS 
rt-PA trial.[30] 
In the latter study, as increasing admission glucose level was 
independently associated with decreased odds for neurological 
improvement (odds ratio, OR = 0.76 per 100 mg/dl increase in admission 
glucose) and the odds ratio for symptomatic intra cerebral hemorrhagic 
was 1.75 per 100 mg/dl increase in admission glucose (95 % CI 1.11 to 
2.78, p = 0.02). The relationship was weaker after excluding patients with 
intra cerebral hemorrhage, suggesting admission hyperglycemia may 
exert its hazard in part through hemorrhagic events. However another 
recent study by Alvarez-Sabin et al found admission glucose more than 
140 mg/dl (OR 8.4, CI 1.8 to 40.0) to be the sole independent predictor of 
poor functional outcome at three months in patients with recanalization 
within six hours, even after excluding the patients symptomatic intra 
cerebral hemorrhage.[31] The same was not true for the patients who did 
not recanalize, which leads to speculation that might partially preclude 
the beneficial effect of r-tPA and early reperfusion.  
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PRIMARY AND SECONDARY PREVENTION  
Atherosclerosis Risk Factors  
Hypertension is the most significant of the risk factors; in general, 
all hypertensives should be treated. Coronary artery disease is the most 
common cause of death in patients with cerebrovascular disease, 
treatment of hypercholesterolemia seems prudent for both the heart and 
brain. Tobacco smoking should be discouraged in all patients  
 
Antiplatelet Agents  
Platelet antiaggregation agents can prevent atherothrombotic 
events, including TIA and stroke, by inhibiting the formation of intra-
arterial platelet aggregates. These can form on diseased arteries, induce 
thrombus formation, and occlude the artery or embolize into the distal 
circulation.  
The antiplatelet agents used most for this purpose are :  
Aspirin, Clopidogrel, and  
The combination of aspirin plus extended-release Dipyridamole  
Anticoagulation Therapy  
ATHEROTHROMBOTIC STROKE  
There are few data to support the use of long-term warfarin for 
preventing atherothrombotic stroke, either intra cranially or extra 
cranially.  
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EMBOLIC STROKE  
Several recent trials demonstrated that anticoagulation (INR range 
2 to 3) in patients with chronic non valvular (non rheumatic) atrial 
fibrillation prevents cerebral embolism and is safe.  
For primary prevention and for patients who have experienced 
stroke or TIA, anticoagulation with warfarin reduces the risk by about 
65% and clearly outweighs the 1% per year rate of major bleeding 
complication.  
Because of the high annual stroke risk in untreated rheumatic heart 
disease, primary prophylaxis against stroke has not been studied in a 
double-blind fashion. These patients generally receive long-term 
anticoagulation.  
Anticoagulation also reduces the risk of embolism in acute 
myocardial infarction. Most clinicians recommend a 3-month course of 
anticoagulation when there is anterior Q-wave infarction, substantial Left 
ventricular dysfunction, congestive heart failure, mural thrombosis, or 
atrial fibrillation .Warfarin is recommended long-term if atrial fibrillation 
persists.  
Thromboembolism is one of the most serious complications of 
prosthetic heart valve implantation. Anticoagulation has been proven 
effective for preventing strokes in this situation, while antiplatelet therapy 
alone has not.  
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However, coupled with warfarin anticoagulation, aspirin adds  
substantial benefit. A greater degree of anticoagulation (INR of 3 to 4, 
depending on valve type) is recommended for prosthetic heart valve 
patients.  
SURGICAL THERAPY  
Surgery for atherosclerotic occlusive disease is largely limited to 
carotid endarterectomy for plaques located at the origin of the internal 
carotid artery in the neck  
Carotid endarterectomy is a proven effective prophylaxis against 
stroke and TIA.  
 
Stroke Centers and Rehabilitation  
Comprehensive stroke units that care for the acute patient followed 
by rehabilitation services have been shown to improve neurological 
outcomes and reduce mortality.  
Proper rehabilitation of the stroke patient includes early physical, 
occupational, and speech therapy. It is directed toward educating the 
patient and family about the patient's neurological deficit, preventing the 
complications of immobility (e.g., pneumonia, deep vein thrombosis and 
pulmonary embolism, pressure sores of the skin, muscle contractures), 
and providing encouragement and instruction in overcoming the deficit. 
The goal of rehabilitation is to return the patient to home and to maximize 
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recovery by providing a safe, progressive regimen suited to the individual 
patient.  
MORTALITY IN STROKE :  
Early mortality (first thirty days ) :  
Generally death occurs with in first 1 days and is secondary to 
large infarction leading to cerebral edema and raised Intra cranial tension. 
These patients can be clinically identified by  
1. Severe fall in level of consciousness.  
2. Gaze paresis.  
3. Hemianopia.  
4. Dilated pupil on the infracted side.  
5. Abnormal type of respiration.  
In such patients CT scan will reveal large hemispherical infarct 
with edema and midline shift and or brain stem infarct.  
 
Other causes after 10 days :  
1. Aspiration pneumonitis.  
2. Bed sores.  
3. Infections.  
4. Pulmonary embolism.  
 
Late mortality :  
Important causes are IHD and recurrent stroke.  
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SUMMARY OF EVIDENCE SUPPORTING A DETRIMENTAL 
ROLE FOR ELEVATED GLUCOSE IN STROKE  
1. Experimental ischemic damage is worsened by hyperglycemia  
2. Experimental ischemic damage is reduced by glucose reduction  
3. Early hyperglycemia is associated with clinical infarct progression 
in brain imaging  
4. Early hyperglycemia is associated with hemorrhagic conversion in 
stroke  
5. Early hyperglycemia is associated with poor clinical outcome  
6. Early hyperglycemia may reduce the benefits of recanalization  
7. Immediate insulin therapy reported beneficial in acute myocardial 
infarction and surgical critical illness.  
 
CONCLUSION  
This recent evidence supports that acutely elevated, predominantly 
stress related hyperglycemia is associated with poor outcome such as 
dependent state or intra cerebral hemorrhage. Through different 
biochemical mechanisms, increased glucose in setting of cerebro vascular 
insults probably accelerates the course of ischemic injury, also in the 
boundary regions with milder perfusion deficit. Although admission 
hyperglycemia has been already demonstrated to be risk factor for 
symptomatic hemorrhage and worsened outcome after thrombotic 
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therapy, there is perhaps not enough evidence to withhold thrombolysis 
from hyperglycemic patients within the three hour time window. How 
ever restoration of normoglycemia as soon as possible should be 
encouraged, although conclusive evidence of decreased risk with this 
approach is lacking. Especially the non diabetic patients may be a risk of 
further brain damage if hyperglycemia prevails. The recent evidence 
summarized above urges corroboration in randomized controlled trial of 
the efficacy of immediate sugar control, and determination of where the 
level of target glucose concentration of relatively different current values 
in the published guidelines (EUSI < 10 mmol/l; ASA < 300 mg/dl) 7 
should be set.  
In the interim, we should fare well with adhering to good general 
stroke management, including control of blood glucose , normalization of 
body temperature, fluid balance and hemodynamics or we may otherwise 
risk the favorable outcome even in the patients with early recanalization.  
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MATERIALS AND METHODS 
 
Total of seventy of acute ischemic stroke patients admitted in the 
Institute of Internal medicine, Madras medical college & RGGGH, 
Chennai between February 2017 to september 2017 were studied. The 
Patients were selected on the following basis  
 
INCLUSION CRITERIA:  
1. Patients should be above the age of forty  
2. Patients should have been admitted within twenty four hours of  
onset of symptoms  
3. This should be the first cerebro vascular accident for the patient  
4. Blood sugar recorded with in twenty four hours of the onset of 
stroke  
 
EXCLUSION CRITERIA:  
1. Patients admitted after twenty four hours of stroke  
2. Those patients who received intravenous glucose before or during 
study period  
3. Patients with reliable information about diabetes could not be 
obtained  
4. Patients who died before it could be established whether or not 
they had diabetes  
5. Illness presented with stroke like symptoms  
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Out of the seventy patients, ten were dropped as follow up could 
not be done.  
Complete history was taken, clinical examination was done and 
clinical diagnosis for each patient was arrived.  
Blood pressure measurement, blood sugar, urea, creatinine, 
electrolytes, hemoglobin, total count, differential count; urine sugar, 
albumin, deposits; electrocardiogram and chest X ray done for all patients  
The severity of stroke for each patient is calculated based on NIH 
stroke scale, NIHSS [32] which takes the following clinical findings in to 
account and each criteria awarded specific points  
1a Level of conscious  
Alert      0  
Drowsy      1    
Stuporous     2  
Comatose     3  
 
1b LOC questions  
Answers both correctly   0    
Answers one correctly   1  
Incorrect     2  
 
1c LOC commands  
Obeys both correctly    0  
Obeys one correctly    1  
Incorrect     2  
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2. Best gaze  
Normal      0   
Partial gaze palsy    1  
Forced deviation    2  
 
3. Visual  
No visual loss     0  
Partial hemianopia    1  
Complete hemianopia   2  
Bilateral hemianopia    3  
 
4. Facial palsy  
Normal symmetric    0  
Minor paralysis    1  
Partial paralysis    2  
Complete paralysis    3  
 
5. Best motor arm (right and left)  
No drift      0  
Drift      1  
Some antigravity effort   2  
No antigravity effort    3  
No movement     4 
 
6. Best motor leg (right and left ) 
No drift      0 
Drift      1 
Some antigravity effort   2 
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No antigravity effort   3  
No movement    4  
 
7. Limb ataxia  
Absent     0  
Present in one limb   1  
Present in both limbs   2  
 
8. Sensory  
No sensory loss    0  
Mild to moderate sensory loss  1  
Total sensory loss    2  
 
9. Best language  
Normal, no aphasia   0  
Mild to moderate aphasia  1  
Severe aphasia    2  
Mute, global aphasia   3    
 
10. Dysarthria  
Normal     0  
Mild to moderate    1  
Severe     2  
 
11. Extinction/ inattention  
No abnormality    0  
Visual/ tactile/ spatial/  
personal inattention   1  
Profound hemi inattention  2  
 
49 
 
The points were added, with a maximum of forty two points.  
 
NIHSS 
Score Stroke severity 
0 No stroke symptoms 
1-4 Minor stroke 
5-15 Moderate stroke 
16-20 Moderate to severe stroke 
21-42 Severe stroke 
 
Once clinical diagnosis of acute stroke is made venous blood 
sample is taken, with in twenty four hours of onset of symptoms, and sent 
to laboratory for glucose estimation.  
In patients with blood sugar more than 6.1 mmol/l(110 mg/dl) [22] 
and without a history of diabetes , Hemoglobin A 1c was performed. 
(Hemoglobin A1c is structurally similar to hemoglobin A except for the 
addition of glucose  
Group to the terminal amino acid of the beta chain of the 
hemoglobin Molecule (glycosylation). Therefore hemoglobin A 1c is a 
function of the exposure of the red blood cells to glucose. Since the 
glucose linkage to hemoglobin is relatively stable, Hemoglobin A1c 
accumulates through out of the life span of erythrocyte and its 
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concentration reflects the integrated blood glucose concentration over a 
period approximating to the half life of erythrocytes i.e. six to eight 
weeks. Therefore measurement of hemoglobin A 1c helps to monitor the 
overall degree of diabetic control achieved). The normal range of 
Hemoglobin A 1c is 3.8% to 6.4%.[33] Hence the patients can be 
classified into four groups  
Blood sugar less than 6.1 mmol/l : Non diabetic (euglycemic)  
History of diabetes : Known diabetics  
Blood sugar more than 6.1mmol/l, no history of diabetes, and 
hemoglobin A1c more than 6.4% : Newly detected diabetics  
Blood sugar more than 6.1 mmol/l, no history of diabetes, and 
hemoglobin A1c less than 6.4% : Stress hyperglycemics  
Then computerized tomography, CT, of the brain was performed in 
all patients to :  
Confirm the diagnosis  
Detect the type of stroke  
Detect the size of lesion (small < 5mm; Medium 5 – 10 mm;  
Large > 10 mm or involving more than one vascular territory)  
Locate the site of lesion  
Identify the presence of cerebral edema or midline shift  
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The patients were followed up for thirty days and outcome in 
the form of death ; poor, moderate and good improvement were 
recorded.  
Patients who were unable to return to any form of work, [34] 
persistent  
Disability,[35] need for residential placement ,[36]dependent 
in activities of daily  
Living , [37]and stable deficit with no recovery [38] were 
classified as those with poor outcome. Patient whose symptoms 
improved, who were independent in attending day to day activities, 
improvement in motor function and aphasia and no persistent 
disability were grouped as patients with good outcome. Patients 
who fared in between these two groups were grouped as those with 
moderate outcome.  
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OBSERVATION AND RESULTS 
 
SEX DISTRIBUTION 
SEX Frequency Percent 
 
MALE 30 60.0 
FEMALE 20 40.0 
Total 50 100.0 
 
 
AGE WISE DISTRIBUTION 
Age Frequency Percent 
 
40-50 YEARS 9 18.0 
51-60 YEARS 15 30.0 
61-70 YEARS 14 28.0 
71-80 YEARS 12 24.0 
Total 50 100.0 
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RISK FACTORS  
 
HYPERTENSION 
 Frequency Percent 
 
NO 18 36.0 
YES 32 64.0 
Total 50 100.0 
 
 
 
 
DIABETES MELLITUS 
 Frequency Percent 
 
NO 16 32.0 
YES 34 68.0 
Total 50 100.0 
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DYSLIPIDEMIA 
 Frequency Percent 
 
NO 21 42.0 
YES 29 58.0 
Total 50 100.0 
 
 
SMOKER 
 Frequency Percent 
 
NO 34 68.0 
YES 16 32.0 
Total 50 100.0 
 
 
ALCOHOLIC 
 Frequency Percent 
 
NO 36 72.0 
YES 14 28.0 
Total 50 100.0 
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GLYCEMIC STATUS  
Based on HbA1c 
 Frequency Percent 
 
EUGLYCEMIC 2 4.0 
KNOWN DIABETIC 32 64.0 
NEWLY DETECTED 7 14.0 
STRESS HYPERGLYCEMICS 9 18.0 
Total 50 100.0 
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HBA1C CLASS
EUGLYCEMIC
KNOWN DIABETIC
NEWLY DETECTED
STRESS HYPERGLYCEMICS
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Based on random blood glucose 
 
 
 
 
 
 
 
  
 Frequency Percent 
 
126-199 20 40.0 
>199 30 60.0 
Total 50 100.0 
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RBS GROUP
126-199
>199
60 
 
STATISTICAL ANALYSIS : 
NIHSS is equated to stroke severity and clinical outcome of patient 
after stroke onset assessed in varying intervals  
NIHSS vs HBA1C 
NIHSS vs HBA1C 
 
Stroke severity 
EUGLYCE
MIC 
KNOW
N 
DIABE
TIC 
NEWLY 
DETECT
ED 
STRESS 
HYPERGLYCE
MICS 
 
NIHSS 
CLASS 
MINOR 
Count 0 1 0 1 2 
% within 
HBA1C 
0.0% 3.1% 0.0% 11.1% 4.0% 
MODERA
TE 
Count 2 11 5 8 26 
% within 
HBA1C 
100.0% 34.4% 71.4% 88.9% 52.0% 
MODERA
TE TO 
SEVERE 
Count 0 10 0 0 10 
% within 
HBA1C 
0.0% 31.2% 0.0% 0.0% 20.0% 
SEVERE 
Count 0 10 2 0 12 
% within 
HBA1C 
0.0% 31.2% 28.6% 0.0% 24.0% 
 
Pearson Chi-Square=21.714* P=0.010 significant 
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COMPARISON OF NIHSS & HBA1C LEVEL 
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NIHSS VS RANDOM BLOOD SUGAR LEVELS 
 RBS_GROUP Total 
126-199 >199 
NIHSS 
MINOR 
Count 0 2 2 
% within 
RBS_GROUP 
0.0% 6.7% 4.0% 
MODERATE 
Count 18 8 26 
% within 
RBS_GROUP 
90.0% 26.7% 52.0% 
MODERATE TO 
SEVERE 
Count 1 9 10 
% within 
RBS_GROUP 
5.0% 30.0% 20.0% 
SEVERE 
Count 1 11 12 
% within 
RBS_GROUP 
5.0% 36.7% 24.0% 
Total 
Count 20 30 50 
% within 
RBS_GROUP 
100.0% 100.0% 100.0% 
 
Pearson Chi-Square=21.819** P<0.0001 significant 
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COMPARISON OF NIHSS & RBS 
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COMPARISON OF CLINICAL OUTCOME & RBS 
 
 
 
.  
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DISCUSSION 
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DISCUSSION 
 
AGE, SEX AND RISK FACTORS:  
 
In our study of fifty patients majority of them belonged to male sex 
showing a male preponderance which is commonly seen in most studies. 
Majority of the patients, fifteen were between the age group of 51 to 60. 
Among the fifty patients 32 had hypertension, 34 had diabetes, 29 had 
hypercholesterolemia, 3 had previous history of myocardial infarction, 
and one female patient had atrial fibrillation.  
More than two third of the male patients were smokers and one half 
had history of alcohol intake. 36 patients had right sided weakness and 24 
patients had left sided weakness.  
 
GLYCEMIC STATUS :  
Among the fifty patients in our study group, 30 patients had 
elevated admission day blood glucose level and 20 patients had normal 
blood glucose values. Diabetes was noticed in 32 patients and stress 
hyperglycemia in another 9 patients . Stress hyperglycemia amounted to 
more than one third of the patients  
 
SEVERITY OF STROKE :  
Severity of stroke was assessed with NIH Stroke scaling system. 
Admission day hyperglycemic patients had a higher score when 
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compared to Euglycemic patients , which was statistically significant  
with p = 0.0001. Among the admission day hyperglycemic patients. 
Uncontrolled diabetes patients had the highest mean NIHSS. Hence an 
elevated blood sugar at the time of stroke resulted in severe stroke.  
 
SIZE OF STROKE:  
The size of the lesion were analyzed with the help of CT scan 
brain. Most of the euglycemic patients had small sized infarcts whereas 
majority of the admission day hyperglycemic patients had large sized 
lesion with edema and midline shift. These data’s were statistically 
significant with p = 0.001. Hyperglycemia by virtue of increased 
anaerobic metabolism, increased brain lactate, impaired mitochondrial 
function, vascular disease, increased free radical production, increased 
expression of c-fos and cox-2 causes severe brain injury and large sized 
infarcts. Hyperglycemia can disrupt the blood brain barrier resulting in 
large hemorrhage and hemorrhagic transformation of infarcts.  
 
OUTCOME OF STROKE :  
In this study of hundred acute stroke patients, euglycemic patients 
had a better outcome when compared to admission day hyperglycemic 
patients.  
Euglycemic patients had a better recovery after acute stroke.  
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Seventeny two percent of euglycemic ( patients including treated ) 
had a good functional recovery. On the contrary only three percent of 
admission day hyperglycemic patients had good functional recovery at 
the end of thirty day follow up.  
Early inpatient mortality was high in admission day hyperglycemic 
patients. Fifty percent of the admission day hyperglycemic patients died 
with in the first thirty days. In the euglycemic patients the early case 
fatality rate was only fifteen percent. Hence there was a three fold 
increased risk of early mortality in admission day hyperglycemic patients 
when compared to euglycemics. Poor outcome was noticed in thirty eight 
percent of admission day hyperglycemic patients and in three percent of 
euglycemic patients.  
This study of fifty acute stroke patients shows that admission day 
elevated blood glucose level was associated with a high early mortality 
rate and an increased risk of poor functional recovery.  
These data’s were statistically significant with χ2=21.819 and 
p=0.0001.  
In the ischemic stroke group early mortality rate was 2.07 % in 
euglycemic patients and 14.8 % in hyperglycemic patients. Poor outcome 
was noticed in 3.18 % in euglycemics and 38.3 % in hyperglycemics. 
Hence hyperglycemia was associated with an increased early mortality 
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rate and poor functional outcome in ischemic stroke group which was 
also statistically significant  
Our study clearly shows a positive correlation ( r = 0.71, p = 0.01 ) 
between admission day sugar value and the outcome of stroke. Higher 
admission day elevated blood glucose level has increased mortality and 
high risk of poor functional recovery.  
 
COMPARISION WITH OTHER STUDIES :  
According to Perttu J. Lindsberg and Risto o Roine [39] 
hyperglycemia was noted in two third ( 66% ) of all ischemic stroke 
patients. In our study hyperglycemia was noticed in 60% of patients with 
ischemic stroke. In their study known diabetes and newly diagnosed 
diabetes contributed one third of cases ( 33% ). In our study the same 
group contributed to 62 %.  
A study published in European journal of Neurology, 2002 
concluded that elevated glucose level after acute stroke is associated with 
higher stroke severity than those with normal level.[40]The mean NIHSS 
was 5.6 in euglycemics and 14.5 in hyperglycemic patients in our study.  
In the journal of clinical endocrinology and metabolism, 2002 a 
study confirmed that patients with newly detected hyperglycemia had a 
significant higher early mortality and a lower functional outcome than 
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patients with a history of diabetes or normoglycemia.[41] Our study in 
hundred acute stroke patients had the same results.  
Sarah E capes et al [22] analyzed thirty two similar studies and 
concluded that hyperglycemic patients had threefold increased early 
mortality than euglycemic patients. After ischemic stroke admission 
hyperglycemia was associated with three fold increased 30 day mortality 
than euglcemics. [22] 
In our study, ischemic patients, who had elevated admission day 
glucose level experienced a three and a half fold increased early mortality 
than euglycemics.  
Similar results were noticed in non diabetic patients. Non diabetic 
stress hyperglycemic patients with ischemic stroke had three and a half 
fold increased early mortality when compared to euglycemics. In the 
diabetic group since the sugar value before the onset of stroke was not 
known, the effect of stress in diabetic group could not be studied.  
The study clearly shows an increased early mortality rate and poor 
functional recovery in patients with diabetes and stress hyperglycemia 
when compared to euglycemics.[22] Hence there is an urgent need to 
confirm the improvement in these patients by normalizing blood sugar. 
Several trails are now under way to improve the out come of Stroke by 
normalizing the blood glucose with human recombinant insulin. Stephan 
M. Vinychuk et al showed that administration of insulin to patients with 
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hyperglycemia improves functional recovery and vital activity of mild to 
moderate ischemic stroke patients. However, other clinical benefits of the 
insulin therapy remain to be determined.  
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CONCLUSION 
 
There is a linear correlation between admission day hyperglycemia 
and ischemic stroke in its severity, size and outcome. The combined 
diabetes and stress hyperglycemics are found to have larger sized severe 
stroke and poor functional outcome in the form of increased mortality. 
There is a good correlation between admission day glucose level and the 
outcome in ischemic stroke. Admission day elevated glucose level was a 
significant predictor of mortality and poor functional outcome after acute 
stroke. Hence, restoration of normoglycemia as soon as possible should 
be encouraged. In the interim, we should fare well with adhering to good 
general stroke management, normalization of body temperature, fluid 
balance and hemodynamics or we may otherwise risk the favorable 
outcome even in the patients with normoglycemia.  
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ANNEXURE 
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PROFORMA 
 
NAME OF THE PATIENT :  
 
AGE : SEX : IP NO :  
ADDRESS : OCCUPATION :  
 
 
CHIEF COMPLAINTS :  
 
 
 
HISTORY OF PRESENTING COMPLAINTS :  
 
 
 
PAST HISTORY :  
 
HT / DM / TIA / PT / BA / COPD / CRF / CAHD / DCMP / RHD / 
AS / MVP / HEPATIC DISEASE / SEIZURES / PSYCHIATRIC 
DISORDERS  
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PERSONAL HISTORY : SMOKING, ALCOHOLISM, DIET  
 
 
GENERAL EXAMINATION :  
 
 
VITALS : BP, PULSE RATE, RESPIRATORY RATE AND PATTERN  
 
 
CLINICAL EXAMINATION :  
 
CENTRAL NERVOUS SYSTEM :  
 
CARDIOVASCULAR SYSTEM :  
 
RESPIRATORY SYSTEM :  
 
ABDOMEN EXAMINATION :  
 
SPINE AND CRANIUM :  
 
CLINICAL DIAGNOSIS :  
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INVESTIGATIONS :  
 
Blood sugar , urea , Serum creatinine  
 
Serum electrolytes : sodium, Potassium  
 
Blood hemoglobin , TC , DC, ESR  
 
Urine albumin , sugar , deposits  
 
Total cholesterol  
 
Electrocardiogram  
 
Chest X ray  
 
CT scan brain  
 
HBA1C  
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FINAL DIAGNOSIS :  
 
 
 
PROGNOSIS (30 DAY FOLLOW UP) : Good / Moderate / Poor / 
Death  
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INFORMATION SHEET 
We are conducting a study on “CLINICAL OUTCOME IN 
ISCHEMIC STROKE PATIENTS WITH HYPERGLYCEMIA.” 
among patients attending Rajiv Gandhi Government General Hospital, 
Chennai and for that your co-operation to undergo relevant investigations 
as per need may be valuable to us. 
The purpose of this study is to find the clinical outcome in 
ischemic stroke patients with hyperglycemia. 
We are selecting certain cases and if you are found eligible, we 
would like to perform extra tests and you will be subjected to a non 
invasive procedure like CT –BRAIN and blood sugar levels. 
The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will be 
shared. 
Taking part in this study is voluntary. You are free to decide 
whether to participate in this study or to withdraw at any time; your 
decision will not result in any loss of benefits to which you are otherwise 
entitled. 
The results of the special study may be intimated to you at the end 
of the study period or during the study if anything is found abnormal 
which may aid in the management or treatment. 
 
Signature of Investigator   Signature/left thumb impression of  
       Participant/Patient attender 
 
Date : 
Place : 
89 
 
  
90 
 
PATIENT CONSENT FORM 
 
Study Detail : “ CLINICAL OUTCOME IN ISCHEMIC STROKE 
PATIENTS WITH HYPERGLYCEMIA” 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
In Patient 
Number 
:  
Patient may check (√) these circles 
a. I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask question and all my 
questions and doubts have been answered to my complete 
satisfaction. ❏ 
b. I understand that my participation in the study is voluntary and that I 
am free to withdraw at any time without giving reason, without my 
legal rights being affected. ❏ 
c. I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities 
will not need my permission to look at my health records, both in 
respect of current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study I agree 
to this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published, 
unless as required under the law. I agree not to restrict the use of any 
data or results that arise from this study. ❏ 
d. I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperate with the 
study team and to immediately inform the study staff if I suffer from 
any deterioration in my health or well being or any unexpected or 
unusual symptoms. ❏ 
e. I hereby consent to participate in this study. ❏ 
f. I hereby give permission to undergo detailed clinical examination 
and relevant investigations as required. ❏ 
 
Signature/thumb impression   Signature of Investigator 
Patient’s Name and Address:  Study Investigator’s Name:   
      Dr.A.ABDUL RAHIM 
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NAME AGE SEX HT DM DYSLIPIDIEMIC SMOKER ALCOHOLIC BP RBS HBA1C CT  BRAIN NIHSS PROGNOSIS
parasuraman 75 M Y Y Y N N 170/100 210 8.1 L FP 14 moderate
johnson 60 M Y N Y Y Y 160/90 173 6.5 R cerebellar 8 good
boopathy 45 M Y Y N N Y 130/80 203 8.5 L PT 17 poor
mathammal 80 F Y N Y N N 180/100 197 6.9 R cerebellar 22 death
kantha 65 F Y Y N N N 160/110 274 9 L FP 10 moderate
parvathy 78 F Y Y N N N 160/90 322 8.7 L FTP 25 death
govindhan 72 M Y N N Y Y 180/110 168 6.5 R GC 12 moderate
yuvaraj 70 M N Y Y Y N 140/90 249 8.7 L PT 16 poor
lakshmi 50 F Y N Y N N 178/110 146 5.8 L FP 7 good
perumal 81 M Y Y Y Y Y 190/100 313 8.9 R FTP 23 death
elumalai 54 M Y N N N N 210/130 289 4.5 L cerebellar 4 good
devaraj 60 M Y Y Y Y N 190/110 254 8.5 R GC 28 death
saheedha 70 F N Y Y N N 150/110 282 7.9 L PT 25 death
kurshith beevi 55 F N N Y N N 190/100 222 6.7 L FTP 21 poor
lakshmanan 45 M N Y Y Y Y 150/90 218 8 L thalamic 8 good
murugan 56 M Y N N Y N 186/110 140 5.6 R GC 10 moderate
ramalingam 80 M N N N N N 180/100 168 5 L FP 5 good
padmavathy 73 F Y N N N N 160/86 151 6 R GC 14 moderate
chandra 65 F Y Y Y N N 170/100 270 7.5 L GC 8 good
laxmibai 54 F N Y N N N 130/80 232 8 R thalamic 4 good
srinivasan 55 M N Y Y Y Y 190/110 320 9.5 L FTP 26 death
selvi 45 F Y Y Y N N 160/90 198 6.7 L GC 7 good
lingammal 75 F Y Y N N N 190/100 210 7 L GC 8 moderate
rajagopal 65 M Y Y N N N 180/100 190 5.9 R  FP 10 moderate
moheen ali 67 M Y Y Y N N 180/110 163 6 R PT 6 good
anbu kannan 42 M N Y Y N N 150/90 197 6.2 R GC 8 good
naguran 56 M N Y Y Y Y 180/100 265 7.5 L GC 19 death
venkaaraman 54 M Y Y N N N 170/80 189 6.6 R cerebellar 5 good
ayyadurai 55 M Y Y Y Y Y 190/100 302 8 R GC 16 poor
kamala 70 F N Y Y N N 180/110 442 9 L FTP 22 death
yakub sahib 72 M Y Y Y N N 200/110 252 7.9 L GC 19 poor
damodharan 62 M Y Y Y Y N 180/100 288 8 R GC 26 death
dilli babu 67 M Y N N N N 160/90 168 5.8 R PT 10 moderate
ajay 50 M Y Y N Y Y 190/110 312 7.5 L GC 22 death
solomon 55 M Y N Y N Y 160/90 166 6.2 R FP 11 poor
deivanai 63 F N Y Y N N 130/80 190 6.9 R GC 8 moderate
ponniyammal 71 F Y Y Y N N 150/100 210 8 R FTP 18 poor
palani 44 M N N N Y Y 180/100 148 5.5 L GC 12 moderate
gajendran 52 M Y N N N N 150/110 183 6 R thalamic 8 good
chinnaponnu 68 F N Y Y N N 130/80 210 6.8 L PT 15 poor
vijayan 49 M N Y N Y Y 150/90 334 8.3 L GC 16 poor
yesuraj 61 M Y Y N N N 190/100 281 7.5 R frontal 11 moderate
thayamma 77 F Y Y Y N N 160/100 190 6.8 R cerebellar 18 poor
david 41 M Y N N Y Y 150/90 222 7.8 R GC 7 good
krishnamoorthy 75 M Y Y Y N N 180/100 301 9 L FP 24 death
anthonyammal 69 F N N Y N N 130/80 130 5.4 R  GC 9 moderate
gowri 63 F Y N N N N 170/110 166 6.3 L PT 7 good
latha 59 F N Y N N N 150/90 249 7 L GC 18 poor
vasantha 58 F N Y Y N N 160/100 421 8.9 R GC 16 poor
HT-Hypertension ; DM – Diabetes ; S – Smoker ; A – Alcohol ; 
Hb A1c – Glycosylated hemoglobin ; L – left ; R – right ; F – frontal infarct; FP – fronto parietal infarct;
PT – Parieto temporal infarct; THA – Thalamic infarct ; CEREBELAR – cerebellar infarct ;
F – Frontal ; FP – fronto parietal ; P – parietal ;
PT – parito temporal ;  GC – ganglio capsular infarct ;
